| |
| |
|
| Insider
Information: |
Luly Jay R. |
| Relationship: |
President and CEO, Dir... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
810,609 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,832,687 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
810,609 |
|
|
| Total
Value |
$9,832,687 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 37.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
President and CEO, Dir... |
2024-02-12 |
810,609 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
President and CEOOfficer |
• • – |
2013-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
329,819 |
|
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-01-02 |
4 |
AS |
$27.96 |
$162,699 |
D/D |
(5,800) |
324,019 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-01-10 |
4 |
OE |
$0.73 |
$183,995 |
D/D |
251,119 |
575,138 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-02-14 |
4 |
AS |
$37.81 |
$220,975 |
D/D |
(5,800) |
569,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-03-10 |
4 |
AS |
$37.61 |
$384,867 |
D/D |
(10,000) |
559,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-04-01 |
4 |
AS |
$38.92 |
$587,542 |
D/D |
(15,000) |
544,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-11-03 |
4 |
AS |
$42.38 |
$637,812 |
D/D |
(15,000) |
529,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-12-01 |
4 |
AS |
$44.99 |
$680,815 |
D/D |
(15,000) |
514,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-12-12 |
4 |
OE |
$0.73 |
$5,169 |
D/D |
7,055 |
521,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-01-05 |
4 |
AS |
$50.23 |
$756,463 |
D/D |
(15,000) |
506,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-02-20 |
4 |
AS |
$35.35 |
$530,289 |
D/D |
(15,000) |
491,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-03-09 |
4 |
AS |
$33.13 |
$500,521 |
D/D |
(15,000) |
476,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-10-23 |
4 |
OE |
$1.21 |
$104,829 |
D/D |
68,700 |
545,093 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2016-03-09 |
4 |
OE |
$2.54 |
$47,199 |
D/D |
18,561 |
563,654 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2016-05-10 |
4 |
OE |
$2.97 |
$74,348 |
D/D |
25,000 |
588,654 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2016-06-10 |
4 |
OE |
$2.97 |
$123,848 |
D/D |
41,645 |
630,299 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,800 |
637,099 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2017-02-13 |
4 |
D |
$29.82 |
$67,919 |
D/D |
(2,278) |
634,821 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
29,337 |
664,158 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-02-12 |
4 |
D |
$76.85 |
$855,439 |
D/D |
(11,132) |
653,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-05-16 |
4 |
AS |
$105.82 |
$1,484,913 |
D/D |
(14,032) |
638,994 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-05-17 |
4 |
AS |
$105.83 |
$1,160,742 |
D/D |
(10,968) |
628,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-07-05 |
4 |
AS |
$123.81 |
$368,568 |
D/D |
(2,977) |
625,049 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-07-06 |
4 |
AS |
$124.26 |
$4,014,892 |
D/D |
(32,023) |
593,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-07-27 |
4 |
OE |
$11.77 |
$99,990 |
D/D |
8,498 |
601,524 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
